Ticker
EVOKCompany Name
EVOKE PHARMA INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -3.62M | $ -1.42 | 1 | 2.55M |
3/31/2025 | $ -3.88M | $ -1.52 | 1 | 2.55M |
12/31/2024 | $ -5.46M | $ -2.87 | 1 | 1.91M |
9/30/2024 | $ -5.32M | $ -3.8 | 1 | 1.4M |
6/30/2024 | $ -5.55M | $ -4.07 | 1 | 1.36M |
3/31/2024 | $ -5.93M | $ -7.84 | 1 | 756.84K |
12/31/2023 | $ -4.98M | $ -17.89 | 1 | 278.59K |
9/30/2023 | $ -6.39M | $ -22.92 | 1 | 278.59K |
6/30/2023 | $ -6.44M | $ -23.13 | 1 | 278.59K |
3/31/2023 | $ -6.61M | $ -23.73 | 1 | 278.59K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / (Shares WA * Share Factor)
(=) OCFPS
OCFPS for EVOKE PHARMA INC is calculated as follows: CF - Operations [ $ -6.07M ] / (Shares WA [ 181.57K ] * Share Factor [ 1 ])
(=) OCFPS [ $ -33.41 ]
Minimum
Dec 31, 2021
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.78K |
---|---|
min | $ -9.04 |
max | $ 11.43 |
average | $ 1.66 |
median | $ 0.9 |
std | $ 3.42 |